Introducing Our Lab Partner: Galaxy Diagnostics
MOMS is proud to partner with Galaxy Diagnostics, a social venture and One Health company on a mission to build awareness and offer the best testing for flea and tick-borne infections.
“In addition to offering the best direct testing for confirmation of Bartonella infection and Lyme Borrelia infection, we also spend a large amount of time working with researchers and clinicians to generate new knowledge about emerging flea and tick-borne diseases,” says Amanda Elam, CEO/Cofounder. “We are excited about this opportunity to further spread awareness of these illnesses through our partnership with My One Medical Source.”
About Galaxy Diagnostics
Galaxy Diagnostics was founded in 2009 with the goal of commercializing a more sensitive test for Bartonella species infection—the key agent responsible for causing cat scratch disease (Bartonella henselae) and trench fever (Bartonella quintana).
Their Bartonella ePCR™ test was developed by Dr. Ed Breitschwerdt and Dr. Ricardo Maggi at North Carolina State University College of Veterinary Medicine. It is the most sensitive and specific test available for confirming active infection of a wide range of Bartonella species.
Historically, Bartonella species were incredibly difficult to detect in patient blood, cerebrospinal fluid, joint fluid or tissue samples, and little was known about its pathogenesis. Research conducted by Galaxy Diagnostics has been instrumental in building awareness of bartonellosis among key stakeholders in medical, public health and veterinary communities.
Their Nanotrap® Urine test for Lyme Borreliosis is the most sensitive and specific test available for confirming active infection of a wide range of Bartonella species. This urine-based Lyme antigen test is based on the innovative Nanotrap® particle technology developed by Ceres Nanosciences. Borrelia burgdorferi is the key agent causing Lyme Disease in the United States and, like Bartonella, are difficult to detect in patient samples.
Today, Galaxy Diagnostics also offers a broader menu of accurate and reliable advanced tests for a number of flea and tick-borne infections:
- Borrelia (Lyme disease)
Galaxy is currently the only diagnostics company in the flea and tick-borne disease market that offers tests guided by the pathobiology of the target organism and powered by revolutionary sample enrichment technologies for low abundance infections. Through their research and testing capabilities, they aim to protect the animal-human bond via the surveillance, prevention and clinical management of flea and tick-borne diseases.
We are thrilled to have Galaxy Diagnostics onboard, and look forward to working with them as they “Go Beyond the Limits of Detection” to advance microbial diagnostics.
Are you a patient with physician-prescribed lab orders or a home test kit for a Galaxy Diagnostics test? Schedule your appointment in the MOMS patient portal.